Indian Science Technology and Engineering facilities Map
 
Supplier Map
Service Map
Preivious Next  

  Digital Catalogue for Technology and Products Development


   Technology and Product Development

    Basic Information

Technology developed: COVID-19 Vaccine (TP19767045078)
Category: Product(Hardware/Material/Software)
Details of Inventor(s):
Inventor Institution/Organization/Company Department Designation
Sameer Kumar Malladi IISc MBU PhD student
Shahbaz Ahmed IISc MBU Research Associate
Raghavan Varadarajan IISC MBU Professor
Suman Pandey Mynvax Private Limited Senior Scientist
Randhir Singh Mynvax Private Limited Senior Scientist
Technical Application Area: Biotechnology
If 'Other', please specify:
Please give more details of new technical application area:
COVID-19 vaccine
Organization(s):
Indian Institute of Science (IISc) Bengaluru
Mynvax Private Limited
Affiliated Ministry: Select One...
Type of technology development: Indigenous
Does the technology help in replacing any import items currently
procured from outside India?
Yes
Does the technology have export potential? Yes
Category of Technology developed: Futuristic
Stage of Development: Lab-scale
Please describe in detail including the TRL Level:
4

    Abstract:

Applications: Thermotolerant COVID-19 vaccine
Advantages: Unlike all COVID19 vaccines currently in clinical development the formulation we have developed is highly thermotolerant Details( publicly available)

    Technology Inputs:

Imported Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Indigenous Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Imported Raw Materials:
Raw Materials Year ITC-HS Code
NA
Indigenous Raw Materials:
Raw Materials Year ITC-HS Code
NA
Existing R&D Facilities used:
Facilities Year ITC-HS Code
Facilities for protein characterization at IISc eg SPR 2020-21

   Patents & Publications:

Patents:
Filed Patents (No.) Granted Patents (No.) Year
1 0 2020-21
Publications:
Submitted (No.) Published (No.) Year
1 0 2020-21

    Commercialization Potential:

Who are the Potential Licensees? Developed jointly with Mynvax Potential licensees are large vaccine manufacturers such as Serum Institute of India Indian Immunologicals etc
What commercially available products address
the same problem?
Company Product Problem Addressed
Several vaccines currently in clinical trials COVID-19
Would you like to develop this invention further with
corporate research support?
No
Would you be interested in participating in cluster based
programs for commercialization research or business
planning for your invention?
No
      Submitted by: Prof KVS Hari Date of Submission: 26-11-2020



Chat Room      Write Review     Talk to Experts


THE VISION
THE MISSION
ABOUT I-STEM
It has always been the basic tenet of the Government of India, in generously funding R&D efforts at academic institutions over the years, that facilities established through such support be made available to those needing them and qualified to make use of them for their own research work
read more >>

However, this was never easy or straightforward for, among other reasons, there was no ready source of information of what facility was available and where. Thanks to the Web, it is much easier today to have a national and regional “inventory of resources”, so as to match users with the resources they need, and to do all this in an efficient and transparent manner.

This can lead to a leap in R&D productivity and greatly enhance the effectiveness of public investment. This is the motivation behind I-STEM.
read less <<
Visitor Hit Counter
Hosted at Indian Institute of Science
Copyright © 2024 I-STEM. All rights reserved.
Audited by: STQC Bengaluru.